Fennec Pharmaceuticals (FENC) Assets Average (2011 - 2026)

Fennec Pharmaceuticals (FENC) has 15 years of Assets Average data on file, last reported at $59.9 million in Q4 2025.

• Quarterly Assets Average rose 15.35% year-over-year to $59.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59.9 million (up 15.35% YoY) and the FY2025 annual result came in at $57.7 million, up 60.84% from the prior year.
• Assets Average improved to $59.9 million in Q4 2025, from $47.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $66.2 million in Q2 2024 to a low of $17.4 million in Q2 2022.
• A 5-year average of $35.6 million and a median of $28.3 million in 2021 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average tumbled 37.94% — and 2024, when it soared 220.8%.
• Tracing FENC's Assets Average over 5 years: stood at $24.2 million in 2021, then advanced by 18.44% to $28.7 million in 2022, then declined by 18.33% to $23.4 million in 2023, then soared by 121.74% to $51.9 million in 2024, then increased by 15.35% to $59.9 million in 2025.
• The last three Assets Average figures came in at $59.9 million (Q4 2025), $47.1 million (Q3 2025), and $45.6 million (Q2 2025), per Business Quant data.